Ipilimumab treatment decreases circulating Tregs and GrMDSC while enhancing CD4+ T cell activation

Benzer Materyaller

• Ipilimumab treatment enhances CD4+ T cell activation while decreasing Treg and MDSC frequency in advanced melanoma patients
  Yazar:: Pico de Coaña, Yago, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• Ipilimumab treatment results in an early decrease in the frequency of circulating granulocytic myeloid derived suppressor cells as well as their arginase1 production
  Yazar:: Gentilcore, Giusy, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• Ipilimumab treatment decreases monocytic MDSCs and increases CD8 effector memory T cells in long-term survivors with advanced melanoma
  Yazar:: de Coaña, Yago Pico, ve diğerleri
  Baskı/Yayın Bilgisi: (2017)
• High expression of ID1 in monocytes is strongly associated with phenotypic and functional MDSC markers in advanced melanoma
  Yazar:: Melief, Jeroen, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• PD-1 checkpoint blockade in advanced melanoma patients: NK cells, monocytic subsets and host PD-L1 expression as predictive biomarker candidates
  Yazar:: Pico de Coaña, Yago, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)